Decoy Enhancer Model of Stem Cell Aging: Heterochromatin Erosion Sequesters Transcription Factors and Drives Quiescence Loss

Hypothesis

Aged stem cells lose heterochromatin compaction, producing a surge of accessible distal enhancer‑like DNA that functions as a decoy for transcription factors (TFs) normally bound at promoters and key enhancers. This decoy effect reduces promoter occupancy of quiescence‑maintaining TFs such as Pax7, increases binding of stress‑responsive TFs (e.g., Jun/Fos AP‑1) at non‑functional sites, and elevates transcriptional noise, thereby weakening the correlation between chromatin accessibility and gene expression.

Mechanistic rationale

• Heterochromatin loss in aging releases repetitive and intergenic sequences that acquire nucleosome‑depleted states detectable by ATAC‑seq (1, 2).
• These newly accessible regions are enriched for AP‑1 motifs and low‑affinity TF sites, creating high‑capacity sinks for TFs (1).
• When TFs are sequestered, promoter‑proximal sites of quiescence genes lose occupancy, leading to reduced transcription despite open chromatin (1).
• Simultaneously, stress‑activated TFs gain access to decoy sites, amplifying AP‑1 signaling and promoting precocious cell‑cycle entry (1).
• The competition between functional and decoy binding sites explains the weak accessibility‑expression correlation observed in aged cells.

Testable predictions

1. Decoy saturation: Artificially increasing the number of AP‑1‑rich decoy sequences in young satellite cells will recapitulate the aged accessibility pattern, reduce Pax7 promoter occupancy, and lower quiescence without altering global heterochromatin marks.
2. TF rescue: Overexpressing a decoy‑resistant Pax7 variant (mutated AP‑1 binding domain) in aged cells will restore promoter occupancy and improve regeneration, even though chromatin remains open.
3. Pharmacological break‑down: Treating aged cells with a small‑molecule inhibitor of AP‑1 dimerization (e.g., T‑5224) will decrease decoy binding, increase functional promoter access, and improve the accessibility‑expression correlation.
4. Reversibility via chromatin compaction: Enhancing heterochromatin formation (e.g., SUV39H1 overexpression) will reduce decoy availability, lower AP‑1 sequestration, and rescue quiescence.

Experimental approach

• Generate decoy plasmids containing tandem AP‑1 motifs flanked by minimal nucleosome‑forming sequences; transfect young satellite cells and perform ATAC‑seq, ChIP‑seq for Pax7 and Jun/Fos, and single‑cell RNA‑seq.
• CRISPR‑knock‑in of Pax7‑DBD mutant in aged satellite cells; assay colony‑forming unit frequency and myofiber regeneration in vivo.
• Treat aged HSCs with AP‑1 inhibitor; measure ATAC‑seq signal at promoters vs distal sites, nascent transcription (EU‑labeling), and competitive repopulation.
• Modulate heterochromatin using CRISPR‑dCas9‑KRAB targeting to satellite repeats; assess decoy burden and functional readouts.

Potential outcomes and falsification

• If decoy insertion fails to alter TF promoter occupancy or quiescence, the hypothesis is weakened.
• If Pax7‑DBD mutant does not restore function despite rescued promoter binding, alternative mechanisms dominate.
• If AP‑1 inhibition does not improve accessibility‑expression correlation, decoy competition may not be the primary driver.

By directly testing whether ectopic accessible DNA acts as a TF sink, this framework links chromatin erosion to transcriptional noise and stem‑cell aging, offering a clear, falsifiable path forward.